Health Condition 1: C920- Acute myeloblastic leukemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ABO-incompatible hematopoietic transplant recipients
Exclusion criteria
Exclusion criteria: 1.Donors plasma with no SAS (non secretors) 2.Donors who are tested positive for transfusion transmissible infection Donor - Department of Transfusion medicine Patient - Medical oncology department
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the change in anti-A anti-B antibody titre levels before and after transfusion of donor plasma having A and B secretary substances in ABO incompatible hematopoietic transplant recipientsTimepoint: Within 24 hours of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| To identify the clinical factors associated with change in anti-A, anti-B titres in ABO incompatible transplant recipients following AB donor plasma transfusion. Timepoint: Immediately after intervention within 24 hours and 4 weeks | — |
Countries
India
Contacts
Jawaharlal Institute of Postgraduate Medical Education and Research